Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systemic autoimmune myopathies: a prospective phase 4 controlled trial of an inactivated virus vaccine against SARS-CoV-2
Samuel Katsuyuki Shinjo, Fernando Henrique Carlos de Souza, Isabela Bruna Pires Borges, et al.
Lara D. Veeken (2021) Vol. 61, Iss. 8, pp. 3351-3361
Open Access | Times Cited: 19

Showing 19 citing articles:

Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis
Ainsley Ryan Yan Bin Lee, Shi Yin Wong, Louis Yi Ann Chai, et al.
BMJ (2022), pp. e068632-e068632
Open Access | Times Cited: 390
COVID‐19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathies
Albert Gil‐Vila, R Naveen, Albert Selva-O’Callaghan, et al.
Muscle & Nerve (2022) Vol. 66, Iss. 4, pp. 426-437
Open Access | Times Cited: 38
Humoral immune response to SARS-CoV-2 vaccines in patients with autoimmune rheumatic diseases
P. M. Corbalán, Rodrigo Hernán Tomas‐Grau, Mariana Pera, et al.
Archives of Medical Research (2025) Vol. 56, Iss. 3, pp. 103141-103141
Closed Access
Immunogenicity, Effectiveness, and Safety of COVID-19 Vaccines in Rheumatic Patients: An Updated Systematic Review and Meta-Analysis
Kuo‐Tung Tang, Bo‐Chueh Hsu, Der‐Yuan Chen
Biomedicines (2022) Vol. 10, Iss. 4, pp. 834-834
Open Access | Times Cited: 26
Efficacy, Immunogenicity, and Safety of COVID-19 Vaccines in Patients with Autoimmune Diseases: A Systematic Review and Meta-Analysis
Alvina Widhani, Anshari Saifuddin Hasibuan, Retia Rismawati, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1456-1456
Open Access | Times Cited: 10
Relapses of idiopathic inflammatory myopathies after vaccination against COVID-19: a real-life multicenter Italian study
Edoardo Conticini, Miriana d’Alessandro, Silvia Grazzini, et al.
Internal and Emergency Medicine (2022) Vol. 17, Iss. 7, pp. 1921-1928
Open Access | Times Cited: 17
Molecular Mimicry and HLA Polymorphisms May Drive Autoimmunity in Recipients of the BNT-162b2 mRNA Vaccine: A Computational Analysis
Rossella Talotta
Microorganisms (2023) Vol. 11, Iss. 7, pp. 1686-1686
Open Access | Times Cited: 9
Phase 4 clinical trials in the era of the Coronavirus Disease (COVID-19) pandemic and their importance to optimize the COVID-19 vaccination
Ana Eliza Garcia Ralise, Taís Mendes Camargo, Fernando Augusto Lima Marson
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 9
COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey
Leonardo Santos Hoff, R Naveen, Samuel Katsuyuki Shinjo, et al.
Rheumatology International (2022) Vol. 43, Iss. 1, pp. 47-58
Open Access | Times Cited: 15
Metabolomics acts as a powerful tool for comprehensively evaluating vaccines approved under emergency: a CoronaVac retrospective study
Xinyu Liu, Congshu Xiao, Pengwei Guan, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
The Immunogenicity and Safety of Three Types of SARS-CoV-2 Vaccines in Adult Patients with Immune-Mediated Inflammatory Diseases: A Longitudinal Cohort Study
Ni Tien, Yu-Chang Chang, Po‐Ku Chen, et al.
Biomedicines (2022) Vol. 10, Iss. 4, pp. 911-911
Open Access | Times Cited: 9
Management of Cancer-Associated Myositis
Albert Selva-O’Callaghan, Ernesto Trallero‐Araguás, Javier Ros, et al.
Current Treatment Options in Rheumatology (2022) Vol. 8, Iss. 4, pp. 91-104
Open Access | Times Cited: 6
Third dose of anti-SARS-CoV-2 inactivated vaccine for patients with RA: Focusing on immunogenicity and effects of RA drugs
Ting Zhao, Bo Wang, Jiayan Shen, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 5
Factors Related to Severity, Hospitalization, and Mortality of COVID-19 Infection among Patients with Autoimmune Diseases
Alvina Widhani, Sukamto Koesnoe, Suzy Maria, et al.
Tropical Medicine and Infectious Disease (2023) Vol. 8, Iss. 4, pp. 227-227
Open Access | Times Cited: 2
COVID-19 mRNA vaccines as hypothetical epigenetic players: Results from an in silico analysis, considerations and perspectives
Rossella Talotta
Vaccine (2023) Vol. 41, Iss. 35, pp. 5182-5194
Closed Access | Times Cited: 2
COVID-19 Vaccine Safety Studies among Vulnerable Populations: A Systematic Review and Meta-analysis of 120 Observational Studies and Randomized Clinical Trials
Sima Mohammadi, Malede Mequanent Sisay, Putri Widi Saraswati, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Coronavirus disease 2019 vaccination in patients with rheumatic diseases: A bibliometric‐based analysis of trends
Xiufang Kong, Wei Wang
Rheumatology & autoimmunity (2024) Vol. 4, Iss. 2, pp. 81-89
Open Access
Setting a context for autoantibodies, autoimmunity, and autoimmune diseases associated with SARS-CoV2
Marvin J. Fritzler
Elsevier eBooks (2023), pp. 1-16
Closed Access
Eficacia y seguridad de vacunas contra SARS-CoV-2 en pacientes con enfermedades reumatológicas autoinmunes
Paola Alexandra Cárdenas Maldonado, Karina Fernanda Pucha Aguinsaca, Mariela de los Ángeles Cárdenas Coello
Revista Vive (2023) Vol. 6, Iss. 17, pp. 547-559
Open Access
Page 1

Scroll to top